Chromium

colony stimulating factor 3 ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30859156 The effects of short-term use of granulocyte colony-stimulating factor on bone metabolism in child cancer patients. 2018 1
2 28097942 CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia. 2017 Jul 2
3 28508228 Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia. 2017 Sep 1
4 23978944 Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia. 2014 Feb 2
5 19438472 Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party. 2009 Jun 1
6 15791811 [Current and new therapeutic strategies in acute myeloid leukemia]. 2005 Mar 1
7 16188671 Treatment of T-Cell lymphoma. 2005 1
8 11978940 Remission induction of refractory anaemia with excess blasts in transformation by sole treatment with granulocyte colony-stimulating factor with persistent chromosomal abnormality. 2002 1
9 11408206 Effects of renal function on pharmacokinetics of recombinant human granulocyte colony-stimulating factor in lung cancer patients. 2001 Jul 3
10 10997975 A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells. 2000 Sep 1
11 9716583 A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. 1998 Sep 1 1
12 9777888 New agents for the treatment of acute myelogenous leukemia: focus on topotecan and retinoids. 1998 Sep 1
13 9001413 Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Club de Réflexion en Hématologie. 1997 Jan 1
14 7507264 High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia. 1993 Dec 1